skin infections

FDA approves new drug for skin infectionsThe Food and Drug Administration has approved Sivextro (tedizolid phosphate, Cubist Pharmaceuticals) for the treatment of acute skin infections.
Sivextro approved to treat skin infectionsFDA has approved the new antibacterial drug tedizolid phosphate (Sivextro, Cubist Pharmaceuticals) to treat adults with skin infections.
FDA drug approvals-June 2014FDA actions in brief, breakthrough therapy designations, fast-track designations, first-time generic approval
FDA approves skin infection drugThe Food and Drug Administration has approved an antibacterial medication for the treatment of adult patients with acute skin infections.
FDA approves new IV antibacterial drug used to treat adults with skin infectionsFDA has approved dalbavancin (Dalvance, Durata Therapeutics) for injection for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
FDA panel suggests approval of two antibiotics for skin infectionsThere could soon be new antibiotics to treat acute skin and skin structure infections on the market after a Food and Drug Administration (FDA) advisory committee recommended approval of two new antibiotics March 31.
Skin abscesses with MRSA: How to manageIt has been more than a decade since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and physicians are still trying to figure out how to diagnose, treat, and prevent this virulent form of staph infection, which is immune to many antibiotics.
  • 1
  • 2